Review of genetic and epigenetic alterations in hepatocarcinogenesis
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Abstract Hepatocellular carcinoma (HCC) is associated with multiple risk factors and is believed to arise from pre‐neoplastic lesions, usually in the background of cirrhosis. However, the genetic and epigenetic events of hepatocarcinogenesis are relatively poorly understood. HCC display gross genomic alterations, including chromosomal instability (CIN), CpG island methylation, DNA rearrangements associated with hepatitis B virus (HBV) DNA integration, DNA hypomethylation and, to a lesser degree, microsatellite instability. Various studies have reported CIN at chromosomal regions, 1p, 4q, 5q, 6q, 8p, 10q, 11p, 16p, 16q, 17p and 22q. Frequent promoter hypermethylation and subsequent loss of protein expression has also been demonstrated in HCC at tumor suppressor gene (TSG), p16, p14, p15, SOCS1, RIZ1, E‐cadherin and 14–3‐3 σ. An interesting observation emerging from these studies is the presence of a methylator phenotype in hepatocarcinogenesis, although it does not seem advantageous to have high levels of microsatellite instability. Methylation also appears to be an early event, suggesting that this may precede cirrhosis. However, these genes have been studied in isolation and global studies of methylator phenotype are required to assess the significance of epigenetic silencing in hepatocarcinogenesis. Based on previous data there are obvious fundamental differences in the mechanisms of hepatic carcinogenesis, with at least two distinct mechanisms of malignant transformation in the liver, related to CIN and CpG island methylation. The reason for these differences and the relative importance of these mechanisms are not clear but likely relate to the etiopathogenesis of HCC. Defining these broad mechanisms is a necessary prelude to determine the timing of events in malignant transformation of the liver and to investigate the role of known risk factors for HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham, J. M., Christensen, E. R., Tester, D. J., Kim, C. Y., Roche, P. C., Burgart, L. J., & Thibodeau, S. N. (1998) · PubMed · Cited by 1,005
Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population
Pisani, P., Bray, F., & Parkin, D. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.1571 · Cited by 730
Yoshikawa, H., Matsubara, K., Qian, G.-S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C., & Herman, J. G. (2001) · Nature Genetics · doi:10.1038/ng0501-29 · Cited by 722
Estimates of the worldwide frequency of twelve major cancers.
Parkin, D. M., Stjernswärd, J., & Muir, C. S. (1984) · Europe PMC (PubMed Central) · Cited by 437
Zingg, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.5.869 · Cited by 321
McGlynn, K. A., Rosvold, E. A., Lustbader, E. D., Hu, Y., Clapper, M. L., Zhou, T., Wild, C. P., Xia, X. L., Baffoe-Bonnie, A., & Ofori-Adjei, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2384 · Cited by 275
Comprehensive allelotyping of human hepatocellular carcinoma
Nagai, H., Pineau, P., Tiollais, P., Buendia, M. A., & Dejean, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201136 · Cited by 274
Kondo, Y., Kanai, Y., Sakamoto, M., Mizokami, M., Ueda, R., & Hirohashi, S. (2000) · Hepatology · doi:10.1053/jhep.2000.19797 · Cited by 273
Emi, M., Fujiwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M., & Nakamura, Y. (1992) · PubMed · Cited by 268
The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas
Kanai, Y., Ushijima, S., Hui, A.-M., Ochiai, A., Tsuda, H., Sakamoto, M., & Hirohashi, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<355::aid-ijc8>3.0.co;2-x · Cited by 253
Iwata, N., Yamamoto, H., Sasaki, S., Itoh, F., Suzuki, H., Kikuchi, T., Kaneto, H., Iku, S., Ozeki, I., Karino, Y., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203898 · Cited by 229
Allelotype study of primary hepatocellular carcinoma
藤森, 実. (1991) · Medical Entomology and Zoology · doi:10.11501/3089422 · Cited by 221
Yamada, T., De Souza, A. T., Finkelstein, S., & Jirtle, R. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10351 · Cited by 208
Miyakura, Y., Sugano, K., Konishi, F., Ichikawa, A., Maekawa, M., Shitoh, K., Igarashi, S., Kotake, K., Koyama, Y., & Nagai, H. (2001) · Gastroenterology · doi:10.1053/gast.2001.29616 · Cited by 203
p16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma
Matsuda, Y., Ichida, T., Matsuzawa, J., Sugimura, K., & Asakura, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70137-x · Cited by 202
Michael-Robinson, J. M., Biemer-Hüttmann, A.-E., Purdie, D. M., Walsh, M. D., Simms, L. A., Biden, K. G., Young, J. P., Leggett, B. A., Jass, J. R., & Radford-Smith, G. L. (2001) · Gut · doi:10.1136/gut.48.3.360 · Cited by 198
Self-citationZhang, X., Xu, H. J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S., Benedict, W. F., & Sekiya, T. (1994) · PubMed · Cited by 194
Wong, I. H., Lo, Y. M., Yeo, W., Lau, W. Y., & Johnson, P. J. (2000) · PubMed · Cited by 190
Mutations Predisposing to Hereditary Nonpolyposis Colorectal Cancer
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60097-4 · Cited by 189
Du, Y., Carling, T., Fang, W., Piao, Z. H., Sheu, J., & Huang, S. (2001) · PubMed · Cited by 189
Souza, A. T. D., Hankins, G. R., Washington, M. K., Fine, R. L., Orton, T. C., & Jirtle, R. L. (1995) · PubMed · Cited by 187
Aging, DNA methylation and cancer
Issa, J.-P. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00019-0 · Cited by 185
Buetow, K. H., Murray, J. C., Israel, J. L., London, W. T., Smith, M., Kew, M., Blanquet, V, Brechot, C., Redeker, A., & Govindarajah, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8852 · Cited by 184
Allelotype study of primary hepatocellular carcinoma.
Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., & Harada, H. (1991) · PubMed · Cited by 170
Iino, H., Simms, L., Young, J., Arnold, J., Winship, I. M., Webb, S. I., Furlong, K. L., Leggett, B., & Jass, J. R. (2000) · Gut · doi:10.1136/gut.47.1.37 · Cited by 169
Self-citationBoige, V., Laurent‐Puig, P., Fouchet, P., Fléjou, J., Monges, G., Bédossa, P., Bioulac‐Sage, P., Capron, F., Schmitz, A., Olschwang, S., et al. (1997) · PubMed · Cited by 132
Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma
Yeh, S., Chen, P., Shau, W., Chen, Y., Lee, P., Chen, J., & Chen, D. (2001) · Gastroenterology · doi:10.1053/gast.2001.27211 · Cited by 95
Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
Sheu, J., Lin, Y.-W., Chou, H.-C., Huang, G.-T., Lee, M., Lin, Y.-H., Huang, S.-Y., Chen, C., Wang, J.-T., Lee, P.-H., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690380 · Cited by 64
Zysman, M., Saka, A., Millar, A., Knight, J., Chapman, W. B., & Bapat, B. V. (2002) · PubMed · Cited by 62
Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma
Sakai, K., Nagahara, H., Abe, K., & Obata, H. (1992) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1992.tb00982.x · Cited by 43
p73 Is up-regulated in a subset of hepatocellular carcinomas
Herath, N. I., Kew, M. C., Whitehall, V., Walsh, M. D., Jass, J. R., Khanna, K. K., Young, J. P., Powell, L. W., Leggett, B., & Macdonald, G. A. (2000) · Hepatology · doi:10.1002/hep.510310309 · Cited by 41
Self-citationHerath, N. I., Kew, M. C., Walsh, M. D., Young, J. P., Powell, L. W., Leggett, B., & Macdonald, G. A. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02704.x · Cited by 16
Self-citation
Cited by
Molecular mechanisms of hepatocellular carcinoma
Aravalli, R. N., Steer, C. J., & Cressman, E. N. K. (2008) · Hepatology · doi:10.1002/hep.22580 · Cited by 625
Reactive Oxygen Species (ROS)––Induced genetic and epigenetic alterations in human carcinogenesis
Ziech, D., Franco, R., Pappa, A., & Panayiotidis, M. I. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.02.015 · Cited by 568
Jiang, J., Gusev, Y., Aderca, I., Mettler, T. A., Nagorney, D. M., Brackett, D. J., Roberts, L. R., & Schmittgen, T. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0523 · Cited by 511
Connolly, E., Melegari, M., Landgraf, P., Tchaikovskaya, T., Tennant, B. C., Slagle, B. L., Rogler, L. E., Zavolan, M., Tuschl, T., & Rogler, C. E. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080096 · Cited by 248
“Human hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide, and although chronic infection with human hepatitis B virus (HBV) or hepatitis C virus is known to be the casual agent for more than 80% of cases, treatment options are limited and patient morbidity is high.(10) The lifetime risk of develo…”
BackgroundGroh, K. J., Carvalho, R. N., Chipman, J. K., Denslow, N. D., Halder, M., Murphy, C. A., Roelofs, D., Rolaki, A., Schirmer, K., & Watanabe, K. H. (2015) · Chemosphere · doi:10.1016/j.chemosphere.2014.09.068 · Cited by 207
“, 2014) as well as in the initiation of cancers (Newbold et al., 2000; Herath et al., 2006; Mirbahai et al., 2011).”
Background
Metadata
- Authors
- HERATH, N. I., LEGGETT, B. A., & MACDONALD, G. A.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 21
- Issue
- 1
- Pages
- 15-21
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W2125313689
- Cited by
- 164
- References
- 38
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.